UK pharma industry welcomes government investment in science

Dec. 19, 2014

The pharmaceutical industry in the United Kingdom has welcomed the government’s Science and Innovation strategy, which was announced last week.

The pharmaceutical industry in the United Kingdom has welcomed the government's Science and Innovation strategy, which was announced last week.

The U.K. government has pledged to invest £5.9 billion ($9.2 billion) to support scientific excellence until 2021, of which £2.9 billion ($4.5 billion) will support large-scale investments, including big data and high-value manufacturing, alongside a £900 million ($1.4 billion) 'capital agility fund' to respond to major challenges as they emerge.

The remaining £3 billion ($4.7 billion) will support individual research projects and laboratories.

Plans include an expansion of the Catapult network of technology and innovation centers, with two more Catapults for Precision Medicine and Energy Systems due to open next year.

Meanwhile, the High Value Manufacturing Catapult will receive £61 million ($96 million) for outreach and technical support for SMEs and £28 million ($44 million) for a new National Formulation Centre to drive manufacturing-based growth.

Welcoming this commitment, Stephen Whitehead, CEO of the Association of the British Pharmaceutical Industry (ABPI) , said: "I hope that the strategy leads to a focus on sharpening the translational focus in academic discovery and bolstering its pull through to commercially viable new therapies. This would help to underpin industry investment in the U.K."

Steve Bates, CEO of the BioIndustry Association (BIA), added: "In the Science and Innovation Strategy it's great to see a long-term government plan setting out capital commitments which take into account several recommendations the BIA made on behalf of its membership and the wider life sciences sector, such as the equitable split in funding for higher education and maintaining the U.K.'s world-class labs alongside large scale investments in major national and international projects."

Sponsored Recommendations

Choosing The Right Partner for CHIPS Act Investments

As the U.S. looks to invest in the semiconductor research and production using CHIPS Act 2022 funding, it's important to choose the right partner.

EMWD Uses Technology to Meet Sustainability Goals

Eastern Municipal Water District pilots artificial intelligence-enabled control and machine learning to help save energy, reduce costs, and improve quality.

Protein Processing Solutions: Automation & Control

For protein processors looking to address industry challenges, improve efficiency, and stay ahead in a competitive market, Rockwell Automation offers tailored automation, control...

Automotive Manufacturing Innovation: Smart Solutions for a Connected Future

Rockwell Automation provides automation and control systems tailored for the automotive and tire industries, supporting electric vehicle production, tire production, battery production...